Evaluation of dermatological acceptability of health products under normal use

Ipclin - Pesquisa Clínica Integrada0 sitesSeptember 30, 2019

Overview

No summary available.

Registry

who.int

Start Date

September 30, 2019

End Date

TBD

Last Updated

2 years ago

Study Type

Intervention

Sponsor

Ipclin - Pesquisa Clínica Integrada

•Female and male. Age 18 to 65 years. Phototype I to IV. Whole skin of the region. Occasional user of category products

•Cutaneous marks in the experimental area that interfere in the evaluation of possible skin reactions (pigmentation disorders, vascular malformations, scarring, increased hairiness, ephelides and nevus in large quantities, sunburns). Pregnant or nursing mothers. Participants with a history of allergy to the material used in the study.
•History of atopy. Participants with a history of allergy to cosmetic products of the category tested. Immunodeficiency carriers. Renal, cardiac or hepatic transplanted. Active cutaneous pathologies that may interfere with the study (vitiligo, psoriasis, lupus, atopic dermatitis). Topical use with corticosteroids in the experimental area up to 8 days before the start of the study. Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study.